Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Dermatology
  • Dermatology News
  • Secukinumab Dose...

Secukinumab Dose Tapering ensures increased effectiveness of plaque psoriasis treatment

Written By : Dr. Kamal Kant Kohli Published On 2022-10-21T19:30:21+05:30  |  Updated On 21 Oct 2022 7:30 PM IST
Secukinumab Dose Tapering ensures increased effectiveness of plaque psoriasis treatment
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

CHINA: According to a research study published in the journal Dermatologic Therapy, tapering off secukinumab dosages for individuals with plaque psoriasis may be just as effective as earlier regimens.

An estimated 2% of the world's population has psoriasis, a chronic inflammatory condition. A recombinant, completely human monoclonal anti-IL-17A antibody called secukinumab has been given FDA approval to treat patients with moderate-to-severe psoriasis and psoriatic arthritis.

"A steady increase in secukinumab dose interval has not previously been examined, despite earlier studies producing positive effectiveness and safety data," the authors stated.

A team under the direction of Xi-Bei Chen from the Department of Dermatology at the Second Affiliated Hospital of Zhejiang University School of Medicine evaluated the feasibility, effectiveness, and safety of gradually increasing the secukinumab dosing interval in patients with plaque psoriasis and contrasted it with the FDA-recommended and approved dose regimen.

By monitoring in the Psoriasis Area and Severity Index (PASI) scores, the researchers in the study were able to calculate the interval time for 83 individuals. At baseline and weeks 0, 1, 2, and 3, secukinumab 300 mg was administered subcutaneously to each participant. Each participant had moderate-to-severe plaque-type psoriasis for at least six months, with or without psoriatic arthritis, and they had to be at least 18 years old. The patient group has previously received either single or combined doses of topical, systemic, phototherapy, or biologic therapy. Patients who had received biologic treatment in the past had at least a month-long washout period. A PASI score of 10 or a body surface area (BSA) of 10% was used by the researchers to identify moderate-to-severe plaque-type psoriasis.

Key findings of the trial:

  • Patients whose baseline PASI improved at week 4 dictated the timing of the subsequent injection until week 36.
  • Because of persistent treatment resistance throughout the study, 3 patients were censored and 6 patients converted to biologic therapy. Two of the patients in this group stopped their therapy at week 12, one at week 24, and three at week 36.
  • The average time from the initial psoriasis diagnosis was 24.8 years, and the average time the condition persisted was 14.84 years. The severity of the condition was also suggested by a mean baseline PASI score of 21.53 and a mean baseline BSA score of 47.76.
  • At weeks 4, 12, and 36, respectively, 80%, 96%, and 95% of patients attained the PASI 75, while at weeks 4, 12, and 36, respectively, 54%, 95%, and 84% of patients attained the PASI 90.
  • Eventually, 28% of patients reached PASI 100 in week 4, 89% in week 12, and 68% in week 36.
  • At week 36, the majority of patients had achieved PASI 75, and the average PASI score was lower than it had been at baseline.
  • 28 individuals experienced adverse events, including 10 infections (nasopharyngitis, fungal infection, conjunctivitis, otitis externa), pruritus (n = 5), eczema (n = 4), headache (n = 1), and inflammatory bowel disease (n = 1), all of which were for safety reasons.

This study "demonstrates the viability of gradually extending the dose interval of secukinumab and may serve as a reference for biologic treatment experience," but more research into this option may benefit from a longer follow-up period and larger sample numbers, the authors concluded.

REFERENCE

Chen, X-B, Zheng, Y-X, Ye, L-R, Chen, X-Y, Man, X-Y. Gradually increasing the dosing interval of Secukinumab for moderate to severe plaque psoriasis: A single-center, uncontrolled, prospective study in 36 weeks. Dermatologic Therapy. 2022;e15911. doi:10.1111/dth.15911

SecukinumabDose Taperingplaque psoriasisDermatologic Therapyhuman monoclonal anti-IL-17A antibodyPsoriatic arthritis
Source : Dermatologic Therapy
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or...

Aspirin in Primary Prevention: Prudent Guideline-Based Approach

Aspirin in Primary Prevention: Prudent Guideline-Based Approach

Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium Sulfide in Seborrheic Dermatitis Management

Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium...

View All

Journal Club Today

Face Wash vs Cleanser: Myths Busted for Sensitive Skin by Dr Aman Dua

Face Wash vs Cleanser: Myths Busted for Sensitive Skin by Dr Aman Dua

View All

Health News Today

Health Bulletin 21/June/2025

Health Bulletin 21/June/2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok